Explore more publications!
Sci-Tech Reporter Solomon Islands
Got News to Share?

Sci-Tech Reporter Solomon Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Reporter Solomon Islands.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 18, 2025

Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease
December 18, 2025

Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease

Indeterminate GlobeNewswire
Clip Money Inc. Secures a US$3 Million Loan from BDC
December 18, 2025

Clip Money Inc. Secures a US$3 Million Loan from BDC

Indeterminate GlobeNewswire
Numab Therapeutics Achieves Milestone in Second Collaboration Project with Boehringer Ingelheim
December 18, 2025

Numab Therapeutics Achieves Milestone in Second Collaboration Project with Boehringer Ingelheim

Indeterminate GlobeNewswire
WISeKey and OISTE Foundation Presented During the World Human Rights Concert at the United Nations Headquarters in Geneva
December 18, 2025

WISeKey and OISTE Foundation Presented During the World Human Rights Concert at the United Nations Headquarters in Geneva

Indeterminate GlobeNewswire
First Patient Dosed in SAB BIO’s SAFEGUARD Clinical Trial of SAB-142 for the Treatment of Stage 3 T1D
December 18, 2025

First Patient Dosed in SAB BIO’s SAFEGUARD Clinical Trial of SAB-142 for the Treatment of Stage 3 T1D

Indeterminate GlobeNewswire
Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care
December 18, 2025

Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care

Indeterminate GlobeNewswire
RESTEM to Participate in the 15th LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference in January 2026
December 18, 2025

RESTEM to Participate in the 15th LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference in January 2026

Indeterminate GlobeNewswire
Larimar Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 18, 2025

Larimar Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus
December 18, 2025

Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus

Indeterminate GlobeNewswire
Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 18, 2025

Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
BigCommerce Partners with Stripe to Support New Agentic Commerce Suite and Empower Merchants to Sell Through AI Agents While Maintaining Security
December 18, 2025

BigCommerce Partners with Stripe to Support New Agentic Commerce Suite and Empower Merchants to Sell Through AI Agents While Maintaining Security

Indeterminate GlobeNewswire
Beacon Therapeutics to Present at the 44th Annual JP Morgan Healthcare Conference
December 18, 2025

Beacon Therapeutics to Present at the 44th Annual JP Morgan Healthcare Conference

Indeterminate GlobeNewswire
Cerence AI Set to Showcase Agentic AI and LLM-Powered Innovations at CES 2026
December 18, 2025

Cerence AI Set to Showcase Agentic AI and LLM-Powered Innovations at CES 2026

Indeterminate GlobeNewswire
CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath
December 18, 2025

CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath

Indeterminate GlobeNewswire
OctoPaul Introduces OSpark.ai, a Free All-In-One AI Assistant That Merges Top Tools Into One Platform
December 18, 2025

OctoPaul Introduces OSpark.ai, a Free All-In-One AI Assistant That Merges Top Tools Into One Platform

Indeterminate GlobeNewswire
Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV)
December 18, 2025

Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV)

Indeterminate GlobeNewswire
zSpace and Labtech Introduce Heavy Vehicle Fundamentals to Strengthen Diesel & Transportation Career Pathways with Immersive AR Learning
December 18, 2025

zSpace and Labtech Introduce Heavy Vehicle Fundamentals to Strengthen Diesel & Transportation Career Pathways with Immersive AR Learning

Indeterminate GlobeNewswire
Revolution Medicines Announces First Patient Randomized in the RASolute 304 Clinical Trial of Daraxonrasib in Resectable Pancreatic Ductal Adenocarcinoma Following Adjuvant Chemotherapy
December 18, 2025

Revolution Medicines Announces First Patient Randomized in the RASolute 304 Clinical Trial of Daraxonrasib in Resectable Pancreatic Ductal Adenocarcinoma Following Adjuvant Chemotherapy

Indeterminate GlobeNewswire
Fusemachines Details Growth Strategy for 2026
December 18, 2025

Fusemachines Details Growth Strategy for 2026

Indeterminate GlobeNewswire
Final, 247th participant randomized and commences treatment in Actinogen’s XanaMIA pivotal phase 2b/3 Alzheimer’s trial
December 18, 2025

Final, 247th participant randomized and commences treatment in Actinogen’s XanaMIA pivotal phase 2b/3 Alzheimer’s trial

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions